Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
3(25%)
Results Posted
29%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_4
1
8%
Ph not_applicable
11
92%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Recruiting3
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (8.3%)
N/A11 (91.7%)

Trials by Status

completed758%
recruiting325%
unknown18%
terminated18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12